(c) 2024 PillSync.com

alfuzosin hydrochloride tablet extended release

1 INDICATIONS AND USAGE Alfuzosin hydrochloride extended-release tablets, USP, an alpha adrenergic antagonist, are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. ( 1 ) Important Limitations of Use: Alfuzosin hydrochloride extended-release tablets, USP are not indicated for treatment of hypertension. ( 1.1 ) Alfuzosin hydrochloride extended-release tablets, USP are not indicated for use in pediatric population. ( 1.1 , 8.4 , 12.3 ) Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. 1.1 Important Limitations of Use Alfuzosin hydrochloride extended-release tablets, USP are not indicated for the treatment of hypertension. Alfuzosin hydrochloride extended-release tablets, USP are not indicated for use in pediatric population.

unichem pharmaceuticals (usa), inc.


2 years ago ROUND WHITE U 155 alfuzosin hydrochloride tablet extended release

ROUND WHITE U 155

2 years ago ROUND WHITE U 155 alfuzosin hydrochloride tablet extended release

U 155 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Afluzosin Hydrochloride Extended-Release Tablets, USP 10 mg white, round, beveled edged tablets with '155' debossed on one side and 'U' debossed on other side. Bottles of 30 : NDC 29300-155-13 Bottles of 90 : NDC 29300-155-19 Bottles of 100 : NDC 29300-155-01 Store at 20 0 to 25 0 C (68 0 to 77 0 F) [see USP Controlled Room Temperature]. Protect from light and moisture. Keep this and all drugs out of reach of children.


More pills like ROUND U 155












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site